Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-033066
Filing Date
2006-05-10
Accepted
2006-05-10 12:16:51
Documents
10
Period of Report
2006-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-9337_110q.htm 10-Q 800058
2 EX-3 a06-9337_1ex3d1.htm EX-3.1 10961
3 EX-10 a06-9337_1ex10d2.htm EX-10.2 439149
4 EX-10 a06-9337_1ex10d3.htm EX-10.3 190972
5 EX-10 a06-9337_1ex10d4.htm EX-10.4 362564
6 EX-10 a06-9337_1ex10d5.htm EX-10.5 461370
7 EX-10 a06-9337_1ex10d6.htm EX-10.6 125641
8 EX-31 a06-9337_1ex31d1.htm EX-31.1 9224
9 EX-31 a06-9337_1ex31d2.htm EX-31.2 8838
10 EX-32 a06-9337_1ex32d1.htm EX-32.1 6447
  Complete submission text file 0001104659-06-033066.txt   2416610
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 06824468
SIC: 2834 Pharmaceutical Preparations